cytori therapeutics (CYTX)

- nasdaq
$2.54 May 21, 2013-04:00 PM ET
Chart_CYTX_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $2.5 Day's Range: $2.5 - $2.58
Open: $2.51 52wk Range: $2.04 - $4.93
P/E Ratio: 0 Volume: 206,642
Beta: 2.25 Avg Vol (3m): 234,936
Div & Yield: Market Cap(Mil.): 168
EPS (ttm): -0.5 P/E (ttm): -5.5

cytori therapeutics News
  • Cytori Therapeutics Posts Q1 Net Loss Of $7.7 Mln Or $0.11/Share On Revenues Of $3.8 Mln
    5/9/2013
  • Cytori Therapeutics Receives US Patent For Methods Of Treating Renal Diseases Using Adipose-derived Regenerative Cells
    3/28/2013
  • Cytori Therapeutics Posts Q4 Loss Per Share Of $0.06 Vs. Loss $0.12 Year Ago
    3/7/2013
  • Cytori Therapeutics Receives CE Mark In Europe For Intravase
    2/25/2013
  • Cytori Therapeutics Prices $20 Mln Public Offering Of Common Stock
    12/14/2012

Next 10 Headlines
Copyright © 2013 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.
Privacy   |   Feedback   |   Sitemap